News Pharma Roche

Roche: New Hope in the Fight Against the Coronavirus

Biotech News | 23.03.2020

The US Food and Drug Administration (FDA) allows the Swiss pharmaceutical company Roche to test its...

Diagnostics News Pharma Roche

Coronavirus: Why Roche’s Diagnostic Test Is a Real Game Changer

Biotech News | 14.03.2020

The Swiss pharmaceutical company Roche developed a new diagnostic test for SARS-CoV-2 which...

News Pharma Roche

Roche’s Esbriet Gets FDA Breakthrough Designation for Interstitial Lung Disease

Biotech News | 03.03.2020

Genentech, a member of the Roche Group, today announced that the FDA has granted Breakthrough...

Dicerna Pharmaceuticals News Pharma Roche

Roche to Pay $200 Million for Rights to RNAi Hepatitis B Drug

Biotech News | 31.10.2019

The Basel-based Swiss pharmaceutical company Roche is spending $200 million for a global licensing...

News Pharma Roche

A Glimmer of Hope for Roche in the Battle for Spark Takeover

Biotech News | 25.10.2019

The employees of the US antitrust authority FTC approve the planned takeover of Spark Therapeutics....

News Pharma Roche

Roche with Strong Growth and Third Full-Year Guidance Increase since January 2019

Biotech News | 17.10.2019

The pharmaceutical giant increased sales by ten percent in the first three quarters, more than...

News Pharma UCB

UCB with $2.5 Billion Takeover of Rare Disease Specialist Ra Pharmaceuticals

Biotech News | 10.10.2019

The Belgian pharma giant UCB, a specialist for neurological and immunological disorders, announced...

News Pharma Roche

Roche Extends Takeover Offer for Spark Therapeutics Again

Biotech News | 30.09.2019

Swiss pharma giant Roche is again extending its takeover offer for Spark Therapeutics. The offer...

News Pfizer Pharma

Pfizer’s JAK Inhibitor Abrocitinib Hits its Primary Endpoint in a Second Phase 3 Trial for Atopic Dermatitis

Biotech News | 27.09.2019

Pfizer’s drug Abrocitinib, an oral inhibitor of the Janus kinase 1 (JAK1), met its primary...

News Novartis Pharma

Novartis Accuses Avexis Ex-Employees of Data Manipulation in Development of Zolgensma

Biotech News | 25.09.2019

According to Novartis, two former high-ranking employees of the subsidiary Avexis are responsible...

News Pharma Roche

British Competition and Markets Authority CMA Wants an In-Depth Examination of Roche’s Takeover of Spark Therapeutics

Biotech News | 25.09.2019

The $4.3 billion takeover of the gene therapy specialist Spark Therapeutics by the Swiss pharma...

News Novo Nordisk Pharma

Important Milestone for Novo Nordisk: FDA Approves Oral Version of its Type 2 Diabetes Drug Semaglutide (Rybelsus)

Biotech News | 21.09.2019

This are great news for the Danish diabetes specialist Novo Nordisk. The American healthcare...

News Novartis Pharma

Novartis Presents Interim Analysis of its Phase 3 trial of Zolgensma in Spinal Muscular Atrophy Type 1

Biotech News | 19.09.2019

The gene therapy player AveXis which was acquired by Novartis for $8.7 billion in 2018 today...

News Novartis Pharma

Novartis Paves the Way Towards a Fourth Indication for Cosentyx: Positive Phase 3 Trial Data in Non-Radiographic Spondyloarthritis

Biotech News | 18.09.2019

The Swiss pharma giant Novartis today announced new data from its phase 3 clinical trial program...

News Novartis Pharma

Novartis Presents Phase 3 Data of its Clinical Trials ASCLEPIOS I and II with Arzerra (Ofatumumab) in Patients with Relapsing Multiple Sclerosis

Biotech News | 14.09.2019

Novartis makes major progress towards the anticipated approval for its multiple sclerosis (MS) drug...

News Pharma Roche

Roche’s IL6 Receptor Antagonist Satralizumab Reduces Relapse Risk in Neuromyelitis Optica Spectrum Disorder

Biotech News | 12.09.2019

Roche has today presented phase 3 clinical trial data on its IL-6 receptor antagonist satralizumab...

Janssen Pharmaceuticals News Pharma

Janssen Reports New Head-to-Head Phase 3 Study Data Demonstrating Ponesimod Superiority versus Aubagio (Teriflunomide) in Patients with Relapsing Multiple Sclerosis

Biotech News | 11.09.2019

Janssen today reported the data of its phase 3 study OPTIMUM at the 35th Congress of The European...

Johnson & Johnson News Pharma

Johnson & Johnson’s Multiple Sclerosis Drug Ponesimod Hits Sanofi Drug Aubagio in Phase 3 Trial

Biotech News | 27.07.2019

Johnson & Johnson announced that it has successfully completed its Phase 3 study program with...

News Novartis Pharma

Novartis Holds on to Sandoz Generics Subsidiary

Biotech News | 27.07.2019

Novartis CEO ends speculation about sale of Sandoz and Hexal Genrika divisions. The aim is to make...

News Pharma Roche

Roche Raises Outlook and Dividend: Share Gains

Biotech News | 25.07.2019

Roche, the Basel-based pharmaceutical group, presented its half-year results this morning. The...